| Open Document File Size: 229,49 KBShare Result on Facebook
Company ADP / / Country United States / / Currency ADP / / IndustryTerm pharmaceutical sales / combination products / / MedicalCondition partial seizures / insomnia / social anxiety disorder / ADHD / Hypertension / bronchospasm / Schizophrenia / dementia / Bacterial infections / morning sickness / diabetic neuropathy / panic disorder / autism / Narcolepsy / nausea / Cardiovascular disease / diabetes / Alzheimer's disease / anxiety disorder / Zollinger Ellison syndrome / pain / phocomelia / Allergic rhinitis / II diabetes mellitus / chronic congestive heart failure / postherpetic neuralgia / Attention-deficit hyperactivity disorder / depression / generalized anxiety disorder / anemia / bipolar disorder / asthma / chronic conditions / / Organization Teratology Society / European Medicines Agency / Public Affairs Committee / FDA / / Person Silver Spring / Emmanuel Fadiran / Leyla Sahin / / Product Venlafaxine / Celebrex / Pioglitazone / Levofloxacin / Olanzapine / Diovan / Valsartan / Nexium / Concerta / Escitalopram / Lexapro / Effexor XR / Donepezil / Cymbalta / Seroquel / Lantus / Advair Diskus / Clopidogrel / Crestor / Spiriva / Plavix / Abilify / Lyrica / Singulair / Lipitor / Levaquin / Januvia / Actos / OxyContin / Aricept / Zyprexa / / ProvinceOrState Maryland / / PublishedMedium British Medical Journal / / URL http /
SocialTag |
Assessment of the Consistency of Pregnancy Labeling Across Therapeutic Classes Onyeka Otugo1, Joy Chou1, Olabode Ogundare1, Christopher Vaughan1, Emmanuel Fadiran, PhD1, Leyla Sahin, MD2 of Women’s Health, FDA 2Pediatr